drugset / Trial / NCT01413048
Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the antihypertensive effect of AGSCT101 tablet in patient with stage 1 to 2 essential hypertension.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-03
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AGSCT101 | Unknown | 12.5 mg | — |
| Comparator | Carvedilol | Other / unclassified | 25 mg | — |